We report that TFF1 transfection into L1-expressing CRC cells inhibits cell proliferation, motility, tumorigenesis, and liver metastasis, and that TFF1 works as a negative regulator of NF-κB signaling by inhibiting the levels of critical components in the NF-κB pathway. Here, NFKB1 is linked to colorectal carcinoma.